One-Carbon Metabolism Associated Vulnerabilities in Glioblastoma: A Review
Altered cell metabolism is a hallmark of cancer cell biology, and the adaptive metabolic strategies of cancer cells have been of recent interest to many groups. Metabolic reprogramming has been identified as a critical step in glial cell transformation, and the use of antimetabolites against gliobla...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2021-06-01
|
| Series: | Cancers |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2072-6694/13/12/3067 |
| _version_ | 1797529472594870272 |
|---|---|
| author | Kimia Ghannad-Zadeh Sunit Das |
| author_facet | Kimia Ghannad-Zadeh Sunit Das |
| author_sort | Kimia Ghannad-Zadeh |
| collection | DOAJ |
| description | Altered cell metabolism is a hallmark of cancer cell biology, and the adaptive metabolic strategies of cancer cells have been of recent interest to many groups. Metabolic reprogramming has been identified as a critical step in glial cell transformation, and the use of antimetabolites against glioblastoma has been investigated. One-carbon (1-C) metabolism and its associated biosynthetic pathways, particularly purine nucleotide synthesis, are critical for rapid proliferation and are altered in many cancers. Purine metabolism has also been identified as essential for glioma tumourigenesis. Additionally, alterations of 1-C-mediated purine synthesis have been identified as commonly present in brain tumour initiating cells (BTICs) and could serve as a phenotypic marker of cells responsible for tumour recurrence. Further research is required to elucidate mechanisms through which metabolic vulnerabilities may arise in BTICs and potential ways to therapeutically target these metabolic processes. This review aims to summarize the role of 1-C metabolism-associated vulnerabilities in glioblastoma tumourigenesis and progression and investigate the therapeutic potential of targeting this pathway in conjunction with other treatment strategies. |
| first_indexed | 2024-03-10T10:15:19Z |
| format | Article |
| id | doaj.art-2273440e0b0f4f7dbc41239241243da4 |
| institution | Directory Open Access Journal |
| issn | 2072-6694 |
| language | English |
| last_indexed | 2024-03-10T10:15:19Z |
| publishDate | 2021-06-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Cancers |
| spelling | doaj.art-2273440e0b0f4f7dbc41239241243da42023-11-22T00:53:01ZengMDPI AGCancers2072-66942021-06-011312306710.3390/cancers13123067One-Carbon Metabolism Associated Vulnerabilities in Glioblastoma: A ReviewKimia Ghannad-Zadeh0Sunit Das1The Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, ON M5G 0A4, CanadaThe Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, ON M5G 0A4, CanadaAltered cell metabolism is a hallmark of cancer cell biology, and the adaptive metabolic strategies of cancer cells have been of recent interest to many groups. Metabolic reprogramming has been identified as a critical step in glial cell transformation, and the use of antimetabolites against glioblastoma has been investigated. One-carbon (1-C) metabolism and its associated biosynthetic pathways, particularly purine nucleotide synthesis, are critical for rapid proliferation and are altered in many cancers. Purine metabolism has also been identified as essential for glioma tumourigenesis. Additionally, alterations of 1-C-mediated purine synthesis have been identified as commonly present in brain tumour initiating cells (BTICs) and could serve as a phenotypic marker of cells responsible for tumour recurrence. Further research is required to elucidate mechanisms through which metabolic vulnerabilities may arise in BTICs and potential ways to therapeutically target these metabolic processes. This review aims to summarize the role of 1-C metabolism-associated vulnerabilities in glioblastoma tumourigenesis and progression and investigate the therapeutic potential of targeting this pathway in conjunction with other treatment strategies.https://www.mdpi.com/2072-6694/13/12/3067glioblastomagliomaone-carbon metabolismde novo purine synthesismetabolic reprogrammingmetabolic treatment |
| spellingShingle | Kimia Ghannad-Zadeh Sunit Das One-Carbon Metabolism Associated Vulnerabilities in Glioblastoma: A Review Cancers glioblastoma glioma one-carbon metabolism de novo purine synthesis metabolic reprogramming metabolic treatment |
| title | One-Carbon Metabolism Associated Vulnerabilities in Glioblastoma: A Review |
| title_full | One-Carbon Metabolism Associated Vulnerabilities in Glioblastoma: A Review |
| title_fullStr | One-Carbon Metabolism Associated Vulnerabilities in Glioblastoma: A Review |
| title_full_unstemmed | One-Carbon Metabolism Associated Vulnerabilities in Glioblastoma: A Review |
| title_short | One-Carbon Metabolism Associated Vulnerabilities in Glioblastoma: A Review |
| title_sort | one carbon metabolism associated vulnerabilities in glioblastoma a review |
| topic | glioblastoma glioma one-carbon metabolism de novo purine synthesis metabolic reprogramming metabolic treatment |
| url | https://www.mdpi.com/2072-6694/13/12/3067 |
| work_keys_str_mv | AT kimiaghannadzadeh onecarbonmetabolismassociatedvulnerabilitiesinglioblastomaareview AT sunitdas onecarbonmetabolismassociatedvulnerabilitiesinglioblastomaareview |